{"filings":[{"id":92372,"accession_number":"0001193125-26-206530","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["1.01","1.02","2.02","2.03","9.01"],"status":"ready","headline":"ATEC Q1 rev $192M (+14%), surgical rev +17%; refinances debt with bank facility saving >$6M/yr","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 total revenue $192M (14% YoY growth); surgical revenue $178M (+17%) driven by 21% case volume growth.","GAAP net loss $34M; non-GAAP net income $0M; adjusted EBITDA $21M (11% margin, up 460 bps YoY).","FY2026 total revenue guided to ~$882M (15% growth); surgical revenue ~$805M; adjusted EBITDA ~$134M (15%).","Entered $175M Term Loan A + $125M revolver led by JPMorgan; refinances prior debt, extends maturity to 2031.","New facility reduces interest expense >$6M annually, with potential >$35M total savings; SOFR+275bps at close."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":192108000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.78,"calibrated_materiality_score":0.78,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":103189,"accession_number":"0001193125-26-088220","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2026-03-03T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Director Ward W. Woods retires from Alphatec board; unvested 4,269 RSUs accelerate","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ward W. Woods retires from Board effective Feb 27, 2026 for personal reasons; no disagreement with company.","Vesting acceleration of 4,269 unvested restricted stock units from June 11, 2025 grant.","Board size reduced to 7 from 8 following Woods' resignation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":103188,"accession_number":"0001193125-26-067062","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alphatec FY2025 revenue $764M (+25% YoY); guides FY2026 ~$890M, raises EBITDA guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full-year 2025 total revenue $764M (+25% YoY); GAAP net loss $143M; non-GAAP net income $8M.","Q4 2025 revenue $213M; adjusted EBITDA $33M (16% margin), expanding 390 bps YoY; positive Q4 free cash flow $8M.","FY2026 guidance: revenue ~$890M (+17%); adj. EBITDA ~$134M (15% of rev, up from $130M); FCF >=$20M.","Surgical revenue $190M in Q4 (+21% YoY); net new surgeon users +23% in Q4, +20% full year.","Valence intraoperative platform cleared and released; EOS Insight proliferation noted."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.96,"consensus_revenue_estimate":null,"consensus_revenue_actual":764155000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":103187,"accession_number":"0001193125-26-009910","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"ATEC prelim FY2025 rev ~$764M (+25%), FY2026 outlook $890M; acquires OsteoAdapt distribution rights","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Preliminary FY2025 total revenue ~$764M (25% growth); surgical revenue grew 26% with volume up 24%.","FY2025 adjusted EBITDA reaffirmed at $91M; cash balance ~$161M; Q4 free cash flow expected $6-8M.","FY2026 outlook: total revenue $890M (17% growth), adjusted EBITDA ~$130M, positive free cash flow ~$20M.","Acquired exclusive U.S. distribution rights for Theradaptive's OsteoAdapt (rhBMP-2 biologic, Phase II for spinal fusion)."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.96,"consensus_revenue_estimate":null,"consensus_revenue_actual":764155000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119425,"accession_number":"0001193125-25-271197","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2025-11-07T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"ATEC board member Jeffrey P. Rydin passes away at 59 after lengthy illness","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Jeffrey P. Rydin, age 59, passed away on November 3, 2025 after a lengthy illness.","Rydin served on ATEC's Board of Directors since June 2017; Special Advisor from September 2016.","He had nearly 30 years of medical device experience, including senior roles at NuVasive, DePuy Spine, and Ellipse Technologies.","CEO Pat Miles highlighted Rydin's key role in ATEC's turnaround and sales channel transformation.","No replacement announced; company did not disclose any operational impact."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119424,"accession_number":"0001193125-25-258609","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"ATEC reports Q3 revenue $197M (+30% YoY), raises FY2025 guidance to $760M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $197M, surgical revenue $177M (+31% YoY); EOS revenue $20M (+29%).","GAAP net loss $29M; non-GAAP net income $4M; adjusted EBITDA $26M (13% margin).","Free cash flow positive $5M in quarter, trailing twelve months also positive.","Full-year 2025 guidance raised: revenue $760M (from $742M), adjusted EBITDA $91M (from $83M).","Net new surgeon users grew 26% YoY, a key leading indicator."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.81,"consensus_revenue_estimate":null,"consensus_revenue_actual":551227000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":135979,"accession_number":"0000950170-25-100924","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"ATEC Q2 revenue $186M (+27.5% YoY), raises FY revenue and EBITDA guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Surgical revenue $168M (+29% YoY); total revenue $186M (+27.5% YoY).","GAAP net loss ($41M); non-GAAP net income $3M; adjusted EBITDA $23M (13% margin, +880 bps YoY).","Raised FY 2025 revenue guidance to $742M (prev. $734M) and adjusted EBITDA to $83M (prev. $78M).","Generated $5M free cash flow; trailing twelve months adjusted EBITDA $62M.","New surgeon adoption grew 21%, a key leading indicator."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.63,"consensus_revenue_estimate":null,"consensus_revenue_actual":354724000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":153011,"accession_number":"0000950170-25-086130","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2025-06-13T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Alphatec stockholders approve doubling authorized shares and equity plan increase","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved amendment to increase authorized common stock from 200M to 400M shares.","Amendment to 2016 equity incentive plan approved, increasing share pool to 38,383,333 shares.","All nine director nominees elected; Deloitte ratified as auditor; say-on-pay approved."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":153010,"accession_number":"0000950170-25-061859","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2025-05-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"ATEC Q1 revenue $169M (+22% YoY); raises FY guidance to $734M; refinances convertible debt to 2030","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Surgical revenue $152M (+24%), driven by 17% procedural volume growth and 18% new surgeon adoption increase.","GAAP net loss $52M; Adjusted EBITDA $11M (6% margin), improving 840 bps YoY.","FY2025 revenue guidance raised to ~$734M (from $732M) and adjusted EBITDA to ~$78M (from $75M).","Refinanced convertible debt extending maturity to 2030; ending cash $153M.","Free cash use improved $55M versus Q1 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":169180000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":153009,"accession_number":"0000950170-25-050434","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2025-04-03T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Alphatec reduces cash salaries 10-50% for NEOs, grants RSUs vesting in Aug and Dec 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Cash base salaries reduced by 10%, 25%, or 50% for NEOs and other executives.","Each NEO granted 3,866 to 21,751 RSUs based on March 31, 2025 closing price.","RSUs vest in two equal installments on Aug 5, 2025 and Dec 5, 2025.","Incentive compensation programs continue to reference pre-reduction base salary."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":171796,"accession_number":"0001193125-25-054786","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2025-03-14T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Alphatec issues $405M 0.75% convertibles due 2030, repurchases $253M of 2026 notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Completed repurchase of $253.0M of its 0.75% convertible senior notes due 2026 on March 10, 2025.","Issued $405.0M of 0.75% convertible senior notes due 2030 (previously announced March 7, 2025).","Cap on shares deliverable upon conversion of new notes is 29,700,000 shares of common stock.","Company will settle conversions in cash and/or shares until authorized shares are increased."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":171795,"accession_number":"0001193125-25-049998","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2025-03-07T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Alphatec issues $405M 0.75% convertible notes due 2030; repurchases $253M 2026 notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $405M principal of 0.75% Convertible Senior Notes due 2030, including $55M from full exercise of initial purchasers' option.","Initial conversion price ~$15.54 per share; interest payable semi-annually, matures March 15, 2030.","Repurchased $253M aggregate principal of outstanding 2026 notes for ~$268.4M cash.","Entered capped call transactions costing ~$42.5M to reduce dilution on conversion; cap price $23.46 per share.","Notes are senior unsecured, redeemable after March 20, 2028 if stock price exceeds 130% of conversion price."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":171794,"accession_number":"0001193125-25-047166","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2025-03-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"ATEC prices upsized $350M 0.75% convertible notes due 2030; to repurchase $253M 2026 notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Pricing of $350M principal (upsized from $300M) of 0.75% convertible senior notes due 2030; initial conversion price ~$15.54 (32.5% premium).","Net proceeds estimated at $339M ($392.4M if full greenshoe of additional $55M exercised).","Will use ~$268.4M net proceeds to repurchase $253M aggregate principal of 0.75% convertible notes due 2026 in concurrent private transactions.","Entered into capped call transactions with cap price $23.46/share to reduce potential dilution upon conversion.","Offering expected to settle March 7, 2025; initial purchasers have 13-day option for additional $55M principal."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":171793,"accession_number":"0001193125-25-044094","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2025-03-03T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Alphatec announces $300M convertible notes offering due 2030, repurchases part of 2026 notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Offers $300M aggregate principal of convertible senior notes due 2030; initial purchasers option for additional $50M.","Proceeds used to fund capped call transactions, repurchase outstanding 0.75% 2026 convertible notes, and general corporate purposes.","Concurrently repurchases a portion of its 0.75% convertible notes due 2026 in privately negotiated transactions.","Notes redeemable at ATEC's option after Mar 20, 2028 if stock exceeds 130% of conversion price.","Market information: ATEC estimates U.S. spine TAM at $8B, including $2B lumbar fusion and $1B lateral procedures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":171792,"accession_number":"0000950170-25-027786","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2025-02-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"ATEC FY2024 revenue $612M (+27% YoY); guides FY2025 rev ~$732M, positive FCF","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2024 total revenue $612M, +27% YoY; GAAP net loss $162M; non-GAAP adjusted EBITDA $31M (5% margin).","Q4 revenue $177M; Q4 adjusted EBITDA $21M (12% margin); generated $9M free cash flow; cash $139M.","Surgical revenue +28% in Q4; new surgeon users +20%; first surgery performed in Japan.","FY2025 guidance: revenue ~$732M (+20%), surgical ~$657M, EOS ~$75M, adj. EBITDA ~$75M, positive FCF."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":611562000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":171791,"accession_number":"0000950170-25-004614","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2025-01-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alphatec reports prelim 2024 rev ~$611M (+27% YoY); guides 2025 rev $732M, positive FCF","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Preliminary full-year 2024 total revenue ~$611M (+27% YoY); surgical revenue up 29% to ~$544M.","Year-end 2024 cash ~$139M, up $58M from Q3, inclusive of $50M from term loan expansion.","2025 guidance: total revenue $732M (+20%), surgical $657M, EOS $75M; adjusted EBITDA ~$75M; positive FCF.","Issued 26,013 RSUs as inducement awards to 12 new non-executive employees.","Final Q4/FY2024 results scheduled for release on February 26, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":611562000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":188794,"accession_number":"0000950170-24-119022","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["1.01","2.02","2.03","9.01"],"status":"ready","headline":"ATEC Q3 revenue $151M (+27%), raises FY guidance, adds $50M term loan","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 total revenue $151M, up 27% YoY; surgical revenue grew 30%.","GAAP net loss $40M; adjusted EBITDA $7.4M (5% margin).","Raised FY 2024 revenue guidance to $605M (from $602M) and adjusted EBITDA to ~$27M (from $25.5M).","Expanded existing term loan by $50M to total $200M capacity; pro-forma cash ~$128M.","Procedural volume grew 20%; new surgeon adoption up 19%."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.9,"consensus_revenue_estimate":null,"consensus_revenue_actual":434769000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205266,"accession_number":"0000950170-24-088609","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2024-07-31T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"ATEC Q2 revenue $146M (+25% YoY); raises FY2024 guidance to $602M rev, ~$25.5M adj EBITDA","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $146M (+25% YoY); surgical revenue +27%. GAAP net loss $41M; adjusted EBITDA $5.6M (4% margin).","Full-year 2024 guidance raised: total revenue expected $602M (from $601M); non-GAAP adj EBITDA ~$25.5M (from $23M).","Appointed Keith Valentine as independent director; former CEO of Orthofix and SeaSpine, 30+ years spine industry experience.","Launched EOS Insight integrating AI; record 244 surgeon training engagements; deployed $50M in revenue-generating assets.","Cash balance $100M; ended Q2 with liquidity to support growth."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.63,"consensus_revenue_estimate":null,"consensus_revenue_actual":284050000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222150,"accession_number":"0000950170-24-073859","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2024-06-17T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Alphatec annual meeting: four directors depart, Altman gets accelerated vesting of 6,937 RSUs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Four directors (Altman, Meynadier, Mowry, Tullis) not nominated for re-election; terms ended June 12, 2024.","Altman entered Vesting Acceleration Agreement: 6,937 unvested RSUs from August 2021 grant fully vest.","Stockholders elected nine directors; Mortimer Berkowitz III received 44.7M for vs 37.7M withheld.","Ratified Deloitte as auditor for FY2024 (103.8M for, 35.8K against).","Advisory say-on-pay approved: 69.8M for, 12.6M against, 49.8K abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222149,"accession_number":"0000950170-24-054549","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2024-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"ATEC Q1 revenue up 27% to $138M; raises FY 2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Surgical revenue grew 30% YoY on 23% volume increase and 6% higher average revenue per procedure.","GAAP net loss of $48M; adjusted EBITDA loss of $3M (2% margin), improving 450 bps YoY.","Full-year revenue guidance raised to $601M (from $595M); adjusted EBITDA guidance raised to $23M (from $22M).","Ending cash balance of $144M; deployed ~$60M in revenue-generating assets during Q1.","CEO Pat Miles cites clear line of sight to $1B revenue with innovative spine portfolio."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.34,"consensus_revenue_estimate":null,"consensus_revenue_actual":138477000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":241668,"accession_number":"0000950170-24-033642","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2024-03-19T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Alphatec Holdings discloses holding 2024 Investor Day; no new material information in filing","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Filed under Item 7.01 to disclose investor day presentation given March 19, 2024.","No financial results, guidance, or operational metrics provided in this 8-K.","Slides available on company website under Investors > Events & Presentations.","Information furnished, not filed; not incorporated by reference into SEC filings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":241667,"accession_number":"0000950170-24-021203","cik":1350653,"company_name":"Alphatec Holdings, Inc.","ticker":"ATEC","form_type":"8-K","filed_at":"2024-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alphatec reports FY2023 revenue $482M (+37% YoY); guides FY2024 revenue ~$595M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full-year 2023 revenue $482M, up 37% YoY; Q4 revenue $138M, surgical revenue growth 34%.","GAAP net loss of $187M for FY2023; Q4 net loss $49M.","FY2024 revenue guidance ~$595M, implying ~23% YoY growth; adjusted EBITDA margin expansion ~560 bps.","Adjusted EBITDA (updated definition) FY2023: ($9M) vs prior $4M; Q4: $2M.","Trained over 500 surgeons in 2023; surgeon users up 27% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.54,"consensus_revenue_estimate":null,"consensus_revenue_actual":482262000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1208014991.6277137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}